I
Imran Masood
Researcher at Islamia University
Publications - 53
Citations - 944
Imran Masood is an academic researcher from Islamia University. The author has contributed to research in topics: Medicine & Glaucoma. The author has an hindex of 14, co-authored 42 publications receiving 750 citations. Previous affiliations of Imran Masood include Birmingham City Hospital & King Saud University.
Papers
More filters
Journal ArticleDOI
The role of pharmacists in developing countries: the current scenario in Pakistan
Saira Azhar,Mohamed Azmi Hassali,Mohamed Izham Mohamed Ibrahim,Maqsood Ahmad,Imran Masood,Asrul Akmal Shafie +5 more
TL;DR: Although the pharmacy profession in Pakistan is continuously evolving, the health care system of Pakistan has yet to recognize the pharmacist's role, and this lack of recognition is due to the limited interaction of pharmacists with the public.
Journal ArticleDOI
The PharmD degree in developing countries.
TL;DR: It is imperative to evaluate the state of pharmacy education in India before fully supporting this decision to introduce PharmD (post-bacclaureate degree) courses, and according to the International Pharmaceutical Federation, there must be well-planned execution of good pharmacy practice in developing countries.
Journal ArticleDOI
Pattern of medication selling and self-medication practices: A study from Punjab, Pakistan.
TL;DR: Many types of medicines were often sold without prescription from community pharmacies in Punjab, Pakistan, and self-medication was common practice for a wide range of illnesses.
Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study
Shazia Qasim Jamshed,Mohamed Izham Mohamed Ibrahim,Mohamed Azmi Hassali,Imran Masood,Bee Yean Low,Asrul Akmal Shafie,Zaheer-Ud-Din Babar +6 more
TL;DR: Although good perception and attitude were noted among the respondents, dissemination of information regarding generic medicines may perhaps strengthen generic prescribing, and there is a need to introduce ‘Quality by Design’ concept in local manufacturing units.
Journal ArticleDOI
Prospective Evaluation of Two iStent ® Trabecular Stents, One iStent Supra ® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Jonathan S. Myers,Imran Masood,Dana M. Hornbeak,Jose I. Belda,Gerd U. Auffarth,Anselm Jünemann,Jane Ellen Giamporcaro,Jose M. Martinez-de-la-Casa,Iqbal Ike K. Ahmed,Lilit Voskanyan,L. Jay Katz +10 more
TL;DR: IOP control was achieved safely with two trabecular micro-bypass stents, one suprachoroidal stent, and postoperative prostaglandin in eyes with refractory open angle glaucoma, and this microinvasive, ab interno approach introduces a possible new treatment option forRefractory disease.